Solupore®
non-viral delivery platform for cell engineering
The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients.
About Avectas
Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized.
Find out more about our exciting upcoming events at Avectas
Upcoming Events
Our Partners
Partnerships are essential to ensure better patient outcomes, and we are actively seeking to engage with companies and researchers who are developing these lifesaving gene-modified cell therapy products. Find our current list on our partner page.
Partnerships are essential to ensure better patient outcomes, and we are actively seeking to engage with companies and researchers who are developing these lifesaving gene modified cell therapy products. If you would like to learn more about working with Avectas and our cell engineering technology, get in touch with us.
Join Mailing List
Learn about our non-viral delivery platform including application notes, upcoming webinars, new resources and events.